NCT02920918View on ClinicalTrials.gov

Treatment of Diabetes in Patients With Systolic Heart Failure

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
Heart Failure, SystolicDiabetes Mellitus, Type 2
Interventions
DRUG

Canagliflozin

DRUG

Sitagliptin

Trial Locations (1)

23298

Virginia Commonwealth University, Richmond

All Listed Sponsors
collaborator

Janssen Scientific Affairs, LLC

INDUSTRY

lead

Virginia Commonwealth University

OTHER

NCT02920918 - Treatment of Diabetes in Patients With Systolic Heart Failure | Biotech Hunter | Biotech Hunter